Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231

Clinical Cancer Research

Volumn 7, Issue 9, 2001, Pages 2880-2886

  Lin, Valerie C L ^a   Swee Eng, Aw ^a   Eng Hen, Ng ^a   Ng, Esther H L ^a   Chowdhury, Sanaul H ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE; PROGESTERONE RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROGESTERONE; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRANSFECTION; TRYPSIN; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034803185     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. A pharmacological review of selective estrogen receptor modulators
2. Tamoxifen therapy in primary breast cancer: Biology, efficacy and side effects
3. Role of hormones in mammary cancer initiation and progression
4. Hormones receptors: Their role in predicting prognosis and response to endocrine therapy
5. Molecular markers for predicting response to tamoxifen in breast cancer patients
6. The value of estrogen and progesterone receptors in the treatment of breast cancer
7. Where is the lesion in hormone-independent breast cancer?
8. Mechanisms of hormone independence in human breast cancer
9. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor
10. Progestins inhibit the growth of MDAMB-231 cells transfected with progesterone receptor complementary DNA
11. Progesterone induces cell spreading and focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor cDNA
12. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms
13. Prognostic impact of urokinase-type plasminogen activator (uPA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: A prospective study on multicenter basis
14. Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer
15. A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols
16. Protease levels in breast, ovary, and other gynecological tumor tissues: Prognostic importance in breast cancer
17. Common principles in cell adhesion
18. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
19. The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
20. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
21. Proteolysis in human breast cancer
22. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
23. Urokinase plasminogen activator: A prognostic marker in breast cancer including patients with axillary node-negative disease
24. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor
25. Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines
26. Comparison of in vitro invasiveness of human breast carcinoma in early or late stage with their malignancy in vivo
27. Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines
28. Evaluation of an in vitro invasion assay for use on solid tissue samples and cultured cells